Search Results for "Amneal Pharmaceuticals"
Original Source: Amneal Pharmaceuticals, LLC
Amneal Pharmaceuticals, LLC, with principal offices in Bridgewater, NJ, is a U.S.-based firm that develops, manufactures and distributes generic pharmaceuticals regulated and approved by the U.S. FDA. Known as âGenericâs New Generation,â the company utilizes its newly expanded R&D and manufacturing capabilities to conceive breakthrough developments with lasting impact for a robust product pipeline. Rapid ANDA approvals and diverse product acqui...
Matching Channels
None
Matching News
Amneal Partners with Hanmi to Market Nexium® Alternative
Amneal Pharmaceuticals, LLC today announced that it has entered into a license and distribution agreement with South Korea-based Hanmi Pharmaceutical Co., Ltd to acquire exclusive...
[Hanmi] grants [Amneal] exclusive US distribution rights to esomeprazole strontium
South Korean therapeutics developer [Hanmi Pharmaceutical Co. Ltd.] has licensed generics company [Amneal Pharmaceuticals LLC] exclusive rights to distribute its esomeprazole strontium delayed-release...
Amneal Pharmaceuticals, Hanmi Pharmaceutical deal
Amneal Pharmaceuticals Bucks Trend and Adds U.S. Manufacturing Jobs with Major Expansion
Amneal Pharmaceuticals, LLC today announced that the company is investing $120 million in physical plant capital expenditures from 2012-2014 to significantly grow its operations a...
Amneal Pharmaceuticals Receives FDA Approval for Generic Suboxone®
Amneal Pharmaceuticals, LLC, the 7th largest generic drug manufacturer in the U.S. market, has received U.S. FDA approval for one of the first generic versions of Suboxone® subli...
Amneal to expand manufacturing operations in US
Amneal Pharmaceuticals is investing $120m in physical plant capital expenditures from 2012-2014 to expand its operations at three of its six current manufacturing, R&D and distribution facilities in U...
Amneal to invest $120M to grow U.S. operations, create 500 jobs
Amneal Pharmaceuticals, a manufacturer of generic pharmaceuticals based in Hauppauge, N.Y., is investing $120 million in physical plant capital expenditures from 2012-2014 to significantly grow its op...
FDA approves Amneal’s generic Suboxone to treat opioid drug dependence
Amneal Pharmaceuticals, LLC, the 7th largest generic drug manufacturer in the U.S. market, has received U.S. FDA approval for one of the first generic versions of Suboxone sublingual tablets for maint...
Matching PubMed Articles
None
